Table 2.
Comparison of overall survival rates according to demographic and tumor characteristics. Tumor localization was the characteristic that significantly influenced the overall survival (p=0.044).
Parameter | Survival months (95% confidence interval) | p |
---|---|---|
Sex | 0.26 | |
Male | 150 | |
Female | 100 | |
Tumor localization | 0.044 | |
Head | 100 | |
Body | 56.7±15.5a | |
Tail | 150 | |
Tumor diameter | 0.940 | |
<5 cm | 150 | |
≥5 cm | 150 (79.1–220.1) | |
Perineural invasion | 0.302 | |
Absent | 150 | |
Present | 102.6±6.1a | |
Capsular invasion | 0.323 | |
Absent | 150 | |
Present | 104.3±10.2 | |
Vascular invasion | 0.623 | |
Absent | 150.1±12.0a | |
Present | 150 | |
β-cadherin | 0.857 | |
Negative | 150 | |
Positive | 148.0±13.5a | |
Cytokeratin | 0.320 | |
Negative | 109.3±7.1a | |
Positive | 150 | |
Synaptophysin | 0.931 | |
Negative | 150 | |
Positive | 148.1±13.2a | |
Vimentin | 0.924 | |
Negative | 150 | |
Positive | 146.0±14.5a | |
Chromogranin | 0.212 | |
Negative | 107.3±7.9a | |
Positive | 150 | |
NSE | 0.829 | |
Negative | 150 | |
Positive | 143.2±16.2a | |
CD10 | 0.866 | |
Negative | 150 | |
Positive | 143.7±16.0a | |
CD56 | 0.293 | |
Negative | 100 | |
Positive | 150 | |
Nuclear Atypia | 0.757 | |
Negative | 150 | |
Positive | 142.2±16.6a |
NSE=: neuron-specific enolase; CD: cluster of differentiation
Mean value.